A genetically engineered mighty mouse is helping Medical College of Georgia researchers find the best way for young people to build bone and avoid osteoporosis.
"We are interested in kids; we want to know how to maximize their bone during peak periods of growth while they still can," says Dr. Mark Hamrick, bone biologist. "One of the best predictors of who is going to get osteoporosis and who is not is how much bone you have at sexual maturity. So we want to know what people can do from zero to age 18 that really is going to pack that bone on." These mighty mice, with up to 70 percent more muscle mass than a regular mouse and essentially no body fat, and a $1 million grant from the National Institutes of Health are helping Dr. Hamrick answer that question. The mice lack the myostatin gene, a negative regulator of muscle mass. "Lots of genes control muscle development," says Dr. Hamrick. "This one is pretty significant in terms of not letting muscles get too big."
Myostatin is expressed at highest levels during development, when the embryo is growing, to ensure that muscles dont overgrow, Dr. Hamrick says. The level expressed changes naturally over the course of life. "Its still expressed as children grow and is present in very low levels in adults," he says. "Its suggested that you might get rises in myostatin levels with aging, which is associated with a loss of muscle mass that typically accompanies increased age. " Some muscle-wasting diseases as well as space flight and extended bed rest also are associated with increased myostatin levels. Numerous products claim to help adults build muscle by turning off this powerful muscle regulator produced by muscle cells, Dr. Hamrick says. But the only product scientifically proven to block myostatin is a monoclonal antibody now under study for its potential to treat muscular dystrophy, he says.
Toni Baker | EurekAlert!
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences